Clinuvel Pharmaceuticals
CUV.AX
#7542
Rank
NZ$0.68 B
Marketcap
NZ$13.66
Share price
-0.51%
Change (1 day)
7.91%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2025: NZ$56.58 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are NZ$62.5 Million. In 2025 the company made an earning of NZ$56.58 Million, an increase over its 2024 earnings that were of NZ$56.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025NZ$56.58 M0.26%
2024NZ$56.44 M11.35%
2023NZ$50.68 M28.31%
2022NZ$39.5 M22.8%
2021NZ$32.17 M112.63%
2020NZ$15.12 M-28.73%
2019NZ$21.23 M32.79%
2018NZ$15.98 M75.41%
2017NZ$9.11 M-332.52%
2016-NZ$3.93 Million-70.68%
2015-NZ$13.38 Million53.78%
2014-NZ$8.7 Million-16.1%
2013-NZ$10.37 Million-37.92%
2012-NZ$16.7 Million-18.19%
2011-NZ$20.41 Million25.31%
2010-NZ$16.29 Million-21.53%
2009-NZ$20.76 Million-11.27%
2008-NZ$23.39 Million80.4%
2007-NZ$12.97 Million-2.46%
2006-NZ$13.3 Million-5.35%
2005-NZ$14.05 Million60.55%
2004-NZ$8.75 Million97.37%
2003-NZ$4.44 Million50.62%
2002-NZ$2.95 Million121.22%
2001-NZ$1.34 Million254.48%
2000-NZ$0.38 Million